Relating to restrictions on 340B covered entities.
This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.
- Stage
- Session ended
- Started in
- Senate
- Latest action
- Jun 27, 2025
Where it stands
Introduced (Current step)
Committee (Needs attention)
Floor (Not started)
Law (Not started)
What it does
Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to submit utilization review data as a condition of acquiring, delivering or dispensing 340B drugs.
What moved
Loading recorded actions…
Who is involved
OR SB 533
- Deb PattersonLead sponsor
- James ManningLead sponsor
- Rob NosseLead sponsor
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…